Shares of Concordia Healthcare Corp (TSE:CXR) (NASDAQ:CXRX) have been assigned a consensus recommendation of “Hold” from the seven brokerages that are currently covering the company. Two investment analysts have rated the stock with a sell recommendation and three have issued a hold recommendation on the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is C$30.33.

Several brokerages have weighed in on CXR. Bloom Burton reiterated a “hold” rating on shares of Concordia Healthcare Corp in a report on Wednesday, October 26th. Royal Bank Of Canada lowered their target price on Concordia Healthcare Corp from C$32.00 to C$18.00 and set an “outperform” rating for the company in a report on Tuesday, September 20th. CIBC cut Concordia Healthcare Corp from a “sector perform” rating to an “underperform” rating in a report on Monday, August 15th. Finally, Goldman Sachs Group Inc. lowered their target price on Concordia Healthcare Corp from C$34.00 to C$17.00 in a report on Monday, August 15th.

COPYRIGHT VIOLATION NOTICE: “Concordia Healthcare Corp (CXR) Receives C$30.33 Average Price Target from Analysts” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another publication, it was copied illegally and republished in violation of U.S. & international copyright law. The correct version of this story can be read at https://www.thecerbatgem.com/2016/11/30/concordia-healthcare-corp-cxr-receives-c30-33-average-price-target-from-analysts.html.

Concordia Healthcare Corp (TSE:CXR) opened at 3.54 on Friday. The firm has a 50-day moving average price of $4.40 and a 200 day moving average price of $17.22. The stock’s market capitalization is $180.60 million. Concordia Healthcare Corp has a 12 month low of $2.27 and a 12 month high of $28.35.

About Concordia Healthcare Corp

Receive News & Stock Ratings for Concordia Healthcare Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia Healthcare Corp and related stocks with our FREE daily email newsletter.